Validation of AML-Score in older adults receiving daunorubicin/cytarabine liposome intensive induction chemotherapy for treatment of secondary acute myeloid leukemia.

被引：0
|
作者：
Schmucker, Abigail
Leiby, Benjamin
Wilde, Lindsay
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e19000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19000
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
    C Müller-Tidow
    P Tschanter
    C Röllig
    C Thiede
    A Koschmieder
    M Stelljes
    S Koschmieder
    M Dugas
    J Gerss
    T Butterfaß-Bahloul
    R Wagner
    M Eveslage
    U Thiem
    S W Krause
    U Kaiser
    V Kunzmann
    B Steffen
    R Noppeney
    W Herr
    C D Baldus
    N Schmitz
    K Götze
    A Reichle
    M Kaufmann
    A Neubauer
    K Schäfer-Eckart
    M Hänel
    R Peceny
    N Frickhofen
    M Kiehl
    A Giagounidis
    M Görner
    R Repp
    H Link
    A Kiani
    R Naumann
    T H Brümmendorf
    H Serve
    G Ehninger
    W E Berdel
    U Krug
    Leukemia, 2016, 30 : 555 - 561
  • [32] Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
    Mueller-Tidow, C.
    Tschanter, P.
    Roellig, C.
    Thiede, C.
    Koschmieder, A.
    Stelljes, M.
    Koschmieder, S.
    Dugas, M.
    Gerss, J.
    Butterfass-Bahloul, T.
    Wagner, R.
    Eveslage, M.
    Thiem, U.
    Krause, S. W.
    Kaiser, U.
    Kunzmann, V.
    Steffen, B.
    Noppeney, R.
    Herr, W.
    Baldus, C. D.
    Schmitz, N.
    Goetze, K.
    Reichle, A.
    Kaufmann, M.
    Neubauer, A.
    Schaefer-Eckart, K.
    Haenel, M.
    Peceny, R.
    Frickhofen, N.
    Kiehl, M.
    Giagounidis, A.
    Goerner, M.
    Repp, R.
    Link, H.
    Kiani, A.
    Naumann, R.
    Bruemmendorf, Th
    Serve, H.
    Ehninger, G.
    Berdel, W. E.
    Krug, U.
    LEUKEMIA, 2016, 30 (03) : 555 - 561
  • [33] Frontline Selinexor and Chemotherapy Is Highly Active in Older Adults with Acute Myeloid Leukemia (AML)
    Pardee, Timothy S.
    Pladna, Kristin M.
    Lyerly, Susan
    Dralle, Sarah
    Manuel, Megan
    Ellis, Leslie Renee
    Howard, Dianna S.
    Bhave, Rupali
    Powell, Bayard L.
    BLOOD, 2020, 136
  • [34] The prognostic role of serum albumin in patients receiving induction chemotherapy for acute myeloid leukemia (AML)
    Sadrzadeh, Hossein
    Brunner, Andrew Mark
    Drapkin, Benjamin Jacob
    Babirak, Loren
    Werner, Lillian
    Ballen, Karen K.
    Amrein, Philip C.
    Attar, Eyal C.
    Chen, Yi-Bin Albert
    Spitzer, Thomas R.
    McAfee, Steven L.
    Neuberg, Donna S.
    Fathi, Amir Tahmasb
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
    Baz, Rachid
    Rodriguez, Cristina
    Fu, Alex Z.
    Jawde, Rony Abou
    Kalaycio, Matt
    Advani, Anjali
    Sobecks, Ronald
    Sekeres, Mikkael A.
    CANCER, 2007, 110 (08) : 1752 - 1759
  • [36] Difference Outcome of Pediatric Acute Myeloid Leukemia (AML) Treated with More Intensive Induction Chemotherapy
    Yupensuk, N.
    Torchareon, T.
    Poparn, H.
    Chiengthong, K.
    Techavichit, P.
    Lauhasurayotin, S.
    Sosothikul, D.
    Seksarn, P.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S193 - S193
  • [37] AML THERAPY: IS AZACYTIDINE AN ALTERNATIVE TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKEMIA? A RETROSPECTIVE STUDY ON 334 OLDER AML PATIENTS
    Bories, Pierre
    ANNALS OF HEMATOLOGY, 2013, 92 : S4 - S4
  • [38] FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT
    Candoni, A.
    Simeone, E.
    Michelutti, A.
    Damiani, D.
    Russo, D.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 123 - 123
  • [39] Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study
    Anderson, JE
    Kopecky, KJ
    Willman, CL
    Head, D
    O'Donnell, MR
    Luthardt, FW
    Norwood, TH
    Chen, IM
    Balcerzak, SP
    Johnson, DB
    Appelbaum, FR
    BLOOD, 2002, 100 (12) : 3869 - 3876
  • [40] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345